Requital Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in Ahmedabad, Gujarat, India, established in 2020.
2020 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Requital Pharmaceuticals Private Limited

Requital Pharmaceuticals Private Limited, a active private limited company, was established on 19 November 2020 in Ahmedabad, Gujarat, India. Engaging in specialty within the trading sector, it holds CIN: U51909GJ2020PTC118312. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.30 M.

Its leadership includes Anjali Srivastava (Director), Manish Mishra (Director), Priyank Misra (Director). It is based at Dev 181, A-402, Sterling City Bopal, Daskroi, Ahmedabad, Gujarat, 380058.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909GJ2020PTC118312

  • Registration Number

    118312

  • Incorporation Date

    19 November 2020

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.30 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.30 M
  • Company Age 5 Year, 3 Months
Company report

Requital Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Requital Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Requital Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Anjali Srivastava Director 19 Nov 2020 Current
Manish Mishra Director 19 Nov 2020 Current
Priyank Misra Director 19 Nov 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Requital Pharmaceuticals.

Enhance accessibility to Requital Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Requital Pharmaceuticals revenue growth over time
Requital Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Requital Pharmaceuticals?

Unlock access to Requital Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Requital Pharmaceuticals?

Requital Pharmaceuticals has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Requital Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Requital Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Requital Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Anjali Srivastava was appointed as a Director was appointed as a Director on 19 Nov 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.

  • Director Appointment

    Manish Mishra was appointed as a Director was appointed as a Director on 19 Nov 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.

  • Director Appointment

    Priyank Misra was appointed as a Director was appointed as a Director on 19 Nov 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.

  • Company Incorporation

    The activity Requital Pharmaceuticals Private Limited was registered on 19 Nov 2020 with Roc Ahmedabad & aged 5 years 3 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Requital Pharmaceuticals Private Limited?

The CIN of Requital Pharmaceuticals Private Limited is U51909GJ2020PTC118312.

Where is Requital Pharmaceuticals Private Limited headquartered?

Requital Pharmaceuticals Private Limited is headquartered at Dev 181, A-402, Sterling City Bopal, Daskroi, Ahmedabad, Gujarat, 380058.

When was Requital Pharmaceuticals Private Limited incorporated?

Requital Pharmaceuticals Private Limited was incorporated on 19 November 2020.

Who are the current directors of Requital Pharmaceuticals Private Limited?

The current directors of Requital Pharmaceuticals Private Limited are

What is the primary industry of Requital Pharmaceuticals Private Limited?

The primary industry of Requital Pharmaceuticals Private Limited is Trading.

Is Requital Pharmaceuticals Private Limited a listed company?

Requital Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Requital Pharmaceuticals Private Limited?

The authorized capital of Requital Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.30 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available